Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Modesto de Candia, Gianfranco Lopopolo & Cosimo Altomare. (2009) Novel factor Xa inhibitors: a patent review. Expert Opinion on Therapeutic Patents 19:11, pages 1535-1580.
Read now
Read now
Leo R Zacharski & Agnes YY Lee. (2008) Heparin as an anticancer therapeutic. Expert Opinion on Investigational Drugs 17:7, pages 1029-1037.
Read now
Read now
Jean-Pierre Bassand, Isabelle Richard-Lordereau & Yves Cadroy. (2007) Efficacy and safety of fondaparinux in patients with acute coronary syndromes. Expert Review of Cardiovascular Therapy 5:6, pages 1013-1026.
Read now
Read now
Articles from other publishers (56)
Liangwei Zhang, Yating Liu, Zhuojia Xu, Tianhui Hao, Peng George Wang, Wei Zhao & Tiehai Li. (2022) Design and Synthesis of Neutralizable Fondaparinux. JACS Au 2:12, pages 2791-2799.
Crossref
Crossref
Tanoy Mazumder, Md. Abdus Salam, Shuvo Mitra, Sayem Hossain & Md. Saddam Hussain. (2022) Current antithrombotic therapies and prospects of natural compounds in the management of the thrombotic disorder. Natural Resources for Human Health 3:2, pages 134-175.
Crossref
Crossref
Dandan Zheng, Gui Qi, Isaac Kumi Adu, Haichao Wu & Mingyuan Zhu. (2022) Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis. Medicine 101:39, pages e29483.
Crossref
Crossref
Shweta Sinha, Kuldeep Singh, Akash Ved, Syed Misbahul Hasan & Samar Mujeeb. (2022) Therapeutic Journey and Recent Advances in the Synthesis of Coumarin
Derivatives. Mini-Reviews in Medicinal Chemistry 22:9, pages 1314-1330.
Crossref
Crossref
Prabhu Kumar K.M.Vasantha Kumar B.C.Sharath Kumar M.N.Raghavendra Kumar P.Devaraju S.Butcher R.J.Revanasiddappa H.D.. (2021) Synthesis, structural characterization, CT-DNA interaction study and antithrombotic activity of new ortho-vanillin-based chiral (Se,N,O) donor ligands and their Pd complexes. Inorganica Chimica Acta 528, pages 120609.
Crossref
Crossref
Xinhua Hu, Yichao Xu, Jinliang Chen, Yuting Shen, Dandan Yang, Yin Hu, Bo Jiang, Honggang Lou & Zourong Ruan. (2021) A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study. Journal of Chromatography B 1183, pages 122954.
Crossref
Crossref
Xiujie Liu, Xin Chen, Kai Qiu & Zhihao Zhang. (2019)
Design, synthesis, and biological evaluation of 4‐methoxy‐3‐arylamido‐
N
‐(substitutedphenyl)benzamide derivatives as potential antiplatelet agents
. Archiv der Pharmazie 353:2, pages 1900231.
Crossref
Crossref
Jürgen Arnhold. 2020. Cell and Tissue Destruction. Cell and Tissue Destruction
249
287
.
Hongzhen Jin, Qiang Chen, Yan-Yan Zhang, Kai-Feng Hao, Guo-Qiang Zhang & Wei Zhao. (2019) Preactivation-based, iterative one-pot synthesis of anticoagulant pentasaccharide fondaparinux sodium. Organic Chemistry Frontiers 6:17, pages 3116-3120.
Crossref
Crossref
Supriya Dey, Hong-Jay Lo & Chi-Huey Wong. (2019) An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux. Journal of the American Chemical Society 141:26, pages 10309-10314.
Crossref
Crossref
Yongmei Xu & Jian Liu. 2019. Synthetic Glycomes. Synthetic Glycomes
207
225
.
Patrick Trouilleux, Pierre Potier & Pierre‐Alexandre Driguez. 2019. Protecting Groups. Protecting Groups
473
491
.
Irshad Ahmad, Swati Sharma, Neha Gupta, Qudsia Rashid, Mohammad Abid, Mohammad Z. Ashraf & Mohamad Aman Jairajpuri. (2018) Antithrombotic potential of esculin 7, 3′, 4′, 5′, 6′-O-pentasulfate (EPS) for its role in thrombus reduction using rat thrombosis model. International Journal of Biological Macromolecules 119, pages 360-368.
Crossref
Crossref
Hisham Badreldin. (2018) Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study. Journal of Thrombosis and Thrombolysis 46:1, pages 16-21.
Crossref
Crossref
Xing Zhang & Robert J. Linhardt. 2017. Chemical Biology of Glycoproteins. Chemical Biology of Glycoproteins
233
252
.
Guo-Qiang Zhang, Hongzhen Jin, Yunyan Zhao, Lina Guo, Xue Gao, Xiaoxue Wang, Shiyang Tie, Jie Shen, Peng George Wang, Hao Gan, Huifei Cui & Wei Zhao. (2017) An efficient anticoagulant candidate: Characterization, synthesis and in vivo study of a fondaparinux analogue Rrt1.17. European Journal of Medicinal Chemistry 126, pages 1039-1055.
Crossref
Crossref
Hisham Badreldin, Hunter Nichols, Jessica Rimsans & Danielle Carter. (2016) Evaluation of anticoagulation selection for acute venous thromboembolism. Journal of Thrombosis and Thrombolysis 43:1, pages 74-78.
Crossref
Crossref
Vladimir (Uladzimir) Ladziata, Peter W. Glunz, Yan Zou, Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, Daniel L. Cheney, Anzhi Wei, Joseph M. Luettgen, Timothy M. Harper, Pancras C. Wong, Dietmar Seiffert, Ruth R. Wexler & E. Scott Priestley. (2016) Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters 26:20, pages 5051-5057.
Crossref
Crossref
Marco Mende, Christin Bednarek, Mirella Wawryszyn, Paul Sauter, Moritz B. Biskup, Ute Schepers & Stefan Bräse. (2016) Chemical Synthesis of Glycosaminoglycans. Chemical Reviews 116:14, pages 8193-8255.
Crossref
Crossref
Soo Lee, Wonhwa Lee, Jong-Sup Bae & Eunsook Ma. (2016) Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides. Molecules 21:5, pages 676.
Crossref
Crossref
Xiang Dai, Wentao Liu, Qilong Zhou, Chunwei Cheng, Chao Yang, Shuqing Wang, Min Zhang, Pei Tang, Hao Song, Dan Zhang & Yong Qin. (2015) Formal Synthesis of Anticoagulant Drug Fondaparinux Sodium. The Journal of Organic Chemistry 81:1, pages 162-184.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
383
412
.
Yongshun Huang, Maureen A. Shaw, Eric S. Mullins, Terence L. Kirley & Neil Ayres. (2014) Synthesis and Anticoagulant Activity of Polyureas Containing Sulfated Carbohydrates. Biomacromolecules 15:12, pages 4455-4466.
Crossref
Crossref
Cheng‐Hsiu Chang, Larry S. Lico, Teng‐Yi Huang, Shu‐Yi Lin, Chi‐Liang Chang, Susan D. Arco & Shang‐Cheng Hung. (2014) Synthesis of the Heparin‐Based Anticoagulant Drug Fondaparinux. Angewandte Chemie International Edition 53:37, pages 9876-9879.
Crossref
Crossref
Cheng-Hsiu Chang, Larry S. Lico, Teng-Yi Huang, Shu-Yi Lin, Chi-Liang Chang, Susan D. Arco & Shang-Cheng Hung. (2014) Synthesis of the Heparin-Based Anticoagulant Drug Fondaparinux. Angewandte Chemie 126:37, pages 10034-10037.
Crossref
Crossref
Tiehai Li, Hui Ye, Xuefeng Cao, Jiajia Wang, Yonghui Liu, Lifei Zhou, Qiang Liu, Wenjun Wang, Jie Shen, Wei Zhao & Peng Wang. (2014) Total Synthesis of Anticoagulant Pentasaccharide Fondaparinux. ChemMedChem 9:5, pages 1071-1080.
Crossref
Crossref
Yongmei Xu, Chao Cai, Kasemsiri Chandarajoti, Po-Hung Hsieh, Lingyun Li, Truong Q Pham, Erica M Sparkenbaugh, Juzheng Sheng, Nigel S Key, Rafal Pawlinski, Edward N Harris, Robert J Linhardt & Jian Liu. (2014) Homogeneous low-molecular-weight heparins with reversible anticoagulant activity. Nature Chemical Biology 10:4, pages 248-250.
Crossref
Crossref
Mi Mi Wan, Hao Yue Zhu, Wen Juan Qian, Si Qi Tao, Ying Wang & Jian Hua Zhu. (2014) Fabricating a novel porous releaser of heparin. RSC Adv. 4:91, pages 49908-49915.
Crossref
Crossref
Jian Liu & Robert J. Linhardt. (2014) Chemoenzymatic synthesis of heparan sulfate and heparin. Nat. Prod. Rep. 31:12, pages 1676-1685.
Crossref
Crossref
Pierre-Alexandre Driguez, Pierre Potier & Patrick Trouilleux. (2014) Synthetic oligosaccharides as active pharmaceutical ingredients: Lessons learned from the full synthesis of one heparin derivative on a large scale. Natural Product Reports 31:8, pages 980.
Crossref
Crossref
Troy C. Sarich, Gary Peters, Scott D. Berkowitz, Frank Misselwitz, Christopher C. Nessel, Paul Burton, Nancy Cook-Bruns, Anthonie W.A. Lensing, Lloyd Haskell, Elisabeth Perzborn, Dagmar Kubitza, Kenneth T. Moore, Sanjay Jalota, Juergen Weber, Guohua Pan, Xiang Sun, Torsten Westermeier, Andrea Nadel, Leonard Oppenheimer & Peter M. DiBattiste. (2013) Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions. Annals of the New York Academy of Sciences 1291:1, pages 42-55.
Crossref
Crossref
Adriana Cajiao, Ezra Kwok, Bhushan Gopaluni & Jayachandran N. Kizhakkedathu. (2013)
Use of Molecular Dynamics for the Refinement of an Electrostatic Model for the
In Silico
Design of a Polymer Antidote for the Anticoagulant Fondaparinux
. Journal of Medical Engineering 2013, pages 1-11.
Crossref
Crossref
Calvin H. YehJames C. FredenburghJeffrey I. Weitz. (2012) Oral Direct Factor Xa Inhibitors. Circulation Research 111:8, pages 1069-1078.
Crossref
Crossref
Anilkumar R KoreMuthian Shanmugasundaram. (2012) Novel serine protease inhibitors. Pharmaceutical Patent Analyst 1:4, pages 457-468.
Crossref
Crossref
Aaron D. Baldwin, Karyn G. Robinson, Jaimee L. Militar, Christopher D. Derby, Kristi L. Kiick & Robert E. AkinsJr.Jr.. (2012) In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release. Journal of Biomedical Materials Research Part A 100A:8, pages 2106-2118.
Crossref
Crossref
Guocheng Liu, Jiaxi Xu, Ning Chen, Si Zhang, Zhongren Ding & Hongguang Du. (2012) Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents. European Journal of Medicinal Chemistry 53, pages 114-123.
Crossref
Crossref
Koneni V. Sashidhara, Gopala Reddy Palnati, Srinivasa Rao Avula, Surendra Singh, Manish Jain & Madhu Dikshit. (2012) Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives. Bioorganic & Medicinal Chemistry Letters 22:9, pages 3115-3121.
Crossref
Crossref
Daniella Oliveira, Miryam Alvarez-Flores, Adriana Lopes & Ana Chudzinski-Tavassi. (2017) Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi. Thrombosis and Haemostasis 108:09, pages 570-578.
Crossref
Crossref
Deyan Luo, Frank M. Szaba, Lawrence W. Kummer, Lawrence L. Johnson, Erik I. Tucker, Andras Gruber, David Gailani & Stephen T. Smiley. (2012) Factor XI-Deficient Mice Display Reduced Inflammation, Coagulopathy, and Bacterial Growth during Listeriosis. Infection and Immunity 80:1, pages 91-99.
Crossref
Crossref
Y. Xu, S. Masuko, M. Takieddin, H. Xu, R. Liu, J. Jing, S. A. Mousa, R. J. Linhardt & J. Liu. (2011) Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins. Science 334:6055, pages 498-501.
Crossref
Crossref
Richard J. Friedman. (2011) Novel Oral Anticoagulants for VTE Prevention in Orthopedic Surgery: Overview of Phase 3 Trials. Orthopedics 34:10, pages 795-804.
Crossref
Crossref
Nandipha Mnonopi, Ruby-Ann Levendal, Michael T. Davies-Coleman & Carminita L. Frost. (2011) The cardioprotective effects of marrubiin, a diterpenoid found in Leonotis leonurus extracts. Journal of Ethnopharmacology 138:1, pages 67-75.
Crossref
Crossref
Elin M. Matsson, Johan E. Palm, Ulf G. Eriksson, Pernilla Bottner, Anna Lundahl, Lars Knutson & Hans Lennernäs. (2011) Effects of Ketoconazole on the In Vivo Biotransformation and Hepatobiliary Transport of the Thrombin Inhibitor AZD0837 in Pigs. Drug Metabolism and Disposition 39:2, pages 239-246.
Crossref
Crossref
Gianfranco Lopopolo, Filomena Fiorella, Modesto de Candia, Orazio Nicolotti, Sophie Martel, Pierre-Alain Carrupt & Cosimo Altomare. (2011) Biarylmethoxy isonipecotanilides as potent and selective inhibitors of blood coagulation factor Xa. European Journal of Pharmaceutical Sciences 42:3, pages 180-191.
Crossref
Crossref
Adriana Cajiao. (2011) . Journal of Medical and Biological Engineering 31:2, pages 129.
Crossref
Crossref
Samuel Chackalamannil. 2010. Accounts in Drug Discovery. Accounts in Drug Discovery
25
50
.
Marc P. Bonaca, Philippe Gabriel Steg, Laurent J. Feldman, John F. Canales, James J. Ferguson, Lars Wallentin, Robert M. Califf, Robert A. Harrington & Robert P. Giugliano. (2009) Antithrombotics in Acute Coronary Syndromes. Journal of the American College of Cardiology 54:11, pages 969-984.
Crossref
Crossref
Juan Pablo Ordovás Baines, Eduardo Climent Grana, Alejandro Jover Botella & Isabel Valero García. (2009) Farmacocinética y farmacodinamia de los nuevos anticoagulantes orales. Farmacia Hospitalaria 33:3, pages 125-133.
Crossref
Crossref
Modesto de Candia, Francesco Liantonio, Andrea Carotti, Raimondo De Cristofaro & Cosimo Altomare. (2009) Fluorinated Benzyloxyphenyl Piperidine-4-carboxamides with Dual Function against Thrombosis: Inhibitors of Factor Xa and Platelet Aggregation. Journal of Medicinal Chemistry 52:4, pages 1018-1028.
Crossref
Crossref
Juan Pablo Ordovás Baines, Eduardo Climent Grana, Alejandro Jover Botella & Isabel Valero García. (2009) Pharmacokinetics and pharmacodynamics of the new oral anticoagulants. Farmacia Hospitalaria (English Edition) 33:3, pages 125-133.
Crossref
Crossref
Alan L. Myers, Vijay V. Upreti, Manoj Khurana & Natalie D. Eddington. (2008) Characterization of Total Plasma Glycosaminoglycan Levels in Healthy Volunteers Following Oral Administration of a Novel Antithrombotic Odiparcil With Aspirin or Enoxaparin. The Journal of Clinical Pharmacology 48:10, pages 1158-1170.
Crossref
Crossref
Takuya Shiraishi, Shojiro Kadono, Masayuki Haramura, Hirofumi Kodama, Yoshiyuki Ono, Hitoshi Iikura, Tohru Esaki, Takaki Koga, Kunihiro Hattori, Yoshiaki Watanabe, Akihisa Sakamoto, Kazutaka Yoshihashi, Takehisa Kitazawa, Keiko Esaki, Masateru Ohta, Haruhiko Sato & Toshiro Kozono. (2008) Factor VIIa inhibitors: Target hopping in the serine protease family using X-ray structure determination. Bioorganic & Medicinal Chemistry Letters 18:16, pages 4533-4537.
Crossref
Crossref
Melanie A Abboud, Saul J Needle, Cynthia L Burns-Kurtis, Richard E Valocik, Paul F Koster, Augustin J Amour, Chuen Chan, David Brown, Laiq Chaudry, Ping Zhou, Angela Patikis, Champa Patel, Anthony J Pateman, Rob J Young, Nigel S Watson & John R Toomey. (2008) Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor. Journal of Cardiovascular Pharmacology 52:1, pages 66-71.
Crossref
Crossref
Nigel Mackman. (2008) Triggers, targets and treatments for thrombosis. Nature 451:7181, pages 914-918.
Crossref
Crossref
Robert J. Young, Alan D. Borthwick, David Brown, Cynthia L. Burns-Kurtis, Matthew Campbell, Chuen Chan, Marie Charbaut, Chun-wa Chung, Máire A. Convery, Henry A. Kelly, N. Paul King, Savvas Kleanthous, Andrew M. Mason, Anthony J. Pateman, Angela N. Patikis, Ivan L. Pinto, Derek R. Pollard, Stefan Senger, Gita P. Shah, John R. Toomey, Nigel S. Watson & Helen E. Weston. (2008) Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with biaryl P4 motifs. Bioorganic & Medicinal Chemistry Letters 18:1, pages 23-27.
Crossref
Crossref
Rehana S. Lovely, Lynn K. Boshkov, Ulla M. Marzec, Stephen R. Hanson & David H. Farrell. (2007) Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. British Journal of Haematology 139:3, pages 494-503.
Crossref
Crossref